Automated detection of critical findings in multi-parametric brain MRI using a system of 3D neural networks.


Journal

Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288

Informations de publication

Date de publication:
25 03 2021
Historique:
received: 18 10 2020
accepted: 08 03 2021
entrez: 26 3 2021
pubmed: 27 3 2021
medline: 21 10 2021
Statut: epublish

Résumé

With the rapid growth and increasing use of brain MRI, there is an interest in automated image classification to aid human interpretation and improve workflow. We aimed to train a deep convolutional neural network and assess its performance in identifying abnormal brain MRIs and critical intracranial findings including acute infarction, acute hemorrhage and mass effect. A total of 13,215 clinical brain MRI studies were categorized to training (74%), validation (9%), internal testing (8%) and external testing (8%) datasets. Up to eight contrasts were included from each brain MRI and each image volume was reformatted to common resolution to accommodate for differences between scanners. Following reviewing the radiology reports, three neuroradiologists assigned each study to abnormal vs normal, and identified three critical findings including acute infarction, acute hemorrhage, and mass effect. A deep convolutional neural network was constructed by a combination of localization feature extraction (LFE) modules and global classifiers to identify the presence of 4 variables in brain MRIs including abnormal, acute infarction, acute hemorrhage and mass effect. Training, validation and testing sets were randomly defined on a patient basis. Training was performed on 9845 studies using balanced sampling to address class imbalance. Receiver operating characteristic (ROC) analysis was performed. The ROC analysis of our models for 1050 studies within our internal test data showed AUC/sensitivity/specificity of 0.91/83%/86% for normal versus abnormal brain MRI, 0.95/92%/88% for acute infarction, 0.90/89%/81% for acute hemorrhage, and 0.93/93%/85% for mass effect. For 1072 studies within our external test data, it showed AUC/sensitivity/specificity of 0.88/80%/80% for normal versus abnormal brain MRI, 0.97/90%/97% for acute infarction, 0.83/72%/88% for acute hemorrhage, and 0.87/79%/81% for mass effect. Our proposed deep convolutional network can accurately identify abnormal and critical intracranial findings on individual brain MRIs, while addressing the fact that some MR contrasts might not be available in individual studies.

Identifiants

pubmed: 33767226
doi: 10.1038/s41598-021-86022-7
pii: 10.1038/s41598-021-86022-7
pmc: PMC7994311
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

6876

Subventions

Organisme : NCATS NIH HHS
ID : UL1 TR001433
Pays : United States

Références

Neuroimage Clin. 2017 Jun 13;15:633-643
pubmed: 28664034
Clin Imaging. 2018 May - Jun;49:87-88
pubmed: 29161580
Lancet. 2018 Dec 1;392(10162):2388-2396
pubmed: 30318264
J Am Coll Radiol. 2010 Aug;7(8):650-2
pubmed: 20678736
Br J Radiol. 2004 Mar;77(915):183-8
pubmed: 15020358
Radiology. 2017 Dec;285(3):923-931
pubmed: 28678669
Comput Med Imaging Graph. 2019 Dec;78:101673
pubmed: 31635910
AJNR Am J Neuroradiol. 2018 Sep;39(9):1609-1616
pubmed: 30049723
Med Image Anal. 2017 Dec;42:60-88
pubmed: 28778026
IEEE J Biomed Health Inform. 2017 Jan;21(1):4-21
pubmed: 28055930
NPJ Digit Med. 2018 Apr 4;1:9
pubmed: 31304294
Lancet Neurol. 2010 Feb;9(2):167-76
pubmed: 20056489
Neurology. 2006 Apr 25;66(8):1175-81
pubmed: 16636233
J Neurosurg. 1990 Nov;73(5):688-98
pubmed: 2213158
JAMA. 2013 Jun 19;309(23):2480-8
pubmed: 23780461
Neuroimage Clin. 2016 Jul 02;12:241-51
pubmed: 27489772
Semin Nucl Med. 2019 Mar;49(2):161-165
pubmed: 30819396
PLoS One. 2015 Aug 17;10(8):e0135875
pubmed: 26280918
Ann Neurol. 2005 Sep;58(3):462-5
pubmed: 16130095

Auteurs

Kambiz Nael (K)

Department of Radiological Sciences, David Geffen School of Medicine at University of California Los Angeles, 757 Westwood Plaza, Suite 1621, Los Angeles, CA, 90095-7532, USA. kambiznael@gmail.com.
Department of Diagnostic, Molecular and Interventional Radiology, Icahn School of Medicine at Mount Sinai, New York, USA. kambiznael@gmail.com.

Eli Gibson (E)

Digital Technology and Innovation, Siemens Healthineers, Princeton, USA.

Chen Yang (C)

Department of Diagnostic, Molecular and Interventional Radiology, Icahn School of Medicine at Mount Sinai, New York, USA.

Pascal Ceccaldi (P)

Digital Technology and Innovation, Siemens Healthineers, Princeton, USA.

Youngjin Yoo (Y)

Digital Technology and Innovation, Siemens Healthineers, Princeton, USA.

Jyotipriya Das (J)

Digital Technology and Innovation, Siemens Healthineers, Princeton, USA.

Amish Doshi (A)

Department of Diagnostic, Molecular and Interventional Radiology, Icahn School of Medicine at Mount Sinai, New York, USA.

Bogdan Georgescu (B)

Digital Technology and Innovation, Siemens Healthineers, Princeton, USA.

Nirmal Janardhanan (N)

Digital Technology and Innovation, Siemens Healthineers, Princeton, USA.

Benjamin Odry (B)

AI for Clinical Analytics, Covera Health, New York, NY, USA.

Mariappan Nadar (M)

Digital Technology and Innovation, Siemens Healthineers, Princeton, USA.

Michael Bush (M)

Magnetic Resonance, Siemens Healthineers, New York, USA.

Thomas J Re (TJ)

Digital Technology and Innovation, Siemens Healthineers, Princeton, USA.

Stefan Huwer (S)

Magnetic Resonance, Siemens Healthineers, Erlangen, Germany.

Sonal Josan (S)

Digital Health, Siemens Healthineers, Erlangen, Germany.

Heinrich von Busch (H)

Digital Health, Siemens Healthineers, Erlangen, Germany.

Heiko Meyer (H)

Magnetic Resonance, Siemens Healthineers, Erlangen, Germany.

David Mendelson (D)

Department of Diagnostic, Molecular and Interventional Radiology, Icahn School of Medicine at Mount Sinai, New York, USA.

Burton P Drayer (BP)

Department of Diagnostic, Molecular and Interventional Radiology, Icahn School of Medicine at Mount Sinai, New York, USA.

Dorin Comaniciu (D)

Digital Technology and Innovation, Siemens Healthineers, Princeton, USA.

Zahi A Fayad (ZA)

Department of Diagnostic, Molecular and Interventional Radiology, Icahn School of Medicine at Mount Sinai, New York, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH